NP will turn down any pitiful offer made by big pharma. However any credible offer must be presented to shareholders to vote on. I think any offer being made now will be pitiful. Big pharma would of course increase offers on approval but compared to potential worth they'd still be pitiful. As approvals increase the offers will increase but will always trail true worth until there is no way they can afford us. It will be their curse for underestimating leronlimab and Cytodyn.